MAMina AkbariRad

Mina AkbariRad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mina AkbariRad has a total of 117 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinical Significance of Serum IgG-4 Levels in Autoimmune Hypothyroidism and their Relationship to Thyroid Function Parameters

    by Mina AkbariRad, AmirAli Moodi Ghalibaf, Mitra Ahadi, Ali Tajik, Milad Beizaei, Mohammad Reza Rouhbakhsh Zahmatkesh, Abdollah Firoozi, Zahra Mazloum Khorasani

  • Open Access

    Designing, Implementing, and Evaluating the Portfolio on the Performance of Internal Medicine Residents: An Educational Intervention

    by Mina AkbariRad, Majid Khadem‐Rezaiyan, Mohammad Taheri, AmirAli Moodi Ghalibaf, Abdollah Firoozi, Mitra Ahadi

    Background/Objective: Clinical performance evaluation is one of the critical and sensitive components of the teaching‐learning process. This study evaluates the portfolio evaluation method compared to the log book for internal medicine residents of Mashhad University of Medical Sciences, Mashhad, Iran. Methods: The current study was conducted in 2022–2023 at Mashhad University of Medical Sciences and in Ghaem and Imam Reza hospitals on students (residents) in case of written informed consent. The study tool included ten questions to measure and compare students' satisfaction using the standard logbook and portfolio evaluation methods. In this study, 22 internal medicine residents were included in the logbook group, and 22 were in the portfolio group. Results: According to the results, the portfolio group satisfaction increased in 7 parameters, which include the fairness of the evaluation method ( p = 0.02), the alignment of the subjects in the evaluation method with the goals of the course ( p = 0.016), creating interest and motivation for Student participation in learning in the evaluation method ( p = 0.004), receiving feedback from the instructor about his work in the evaluation method ( p = 0.04), paying attention to different aspects and not being one‐dimensional in the method evaluation ( p = 0.018), paying attention to the progress of the student and not the final situation in the evaluation method ( p = 0.015), helping to find defects and compensate for them in the evaluation method ( p = 0.006). Conclusion: In conclusion, using a portfolio as an evaluation method can have a better effect on residents' training than the old logbook method.

  • Open Access

    Treatment Outcomes of Lobular Granulomatous Mastitis: Impact of Hyperprolactinemia, Diabetes, and Erythema Nodosum—Insights From a 7‐Year Cohort Study

    by Mina AkbariRad, Fereshte Sheybani, Abdollah Firoozi, Samaneh Sajjadi, Maryam Emadzadeh, Marzieh Kazerani, Sajad Ataei Azimi, Mahdieh Mottaghi

    Background: This study presents our observations on the management and follow‐up of patients diagnosed with lobular granulomatous mastitis (LGM) in a cohort study. Additionally, characteristics associated with a longer disease course, as well as treatment challenges in patients with erythema nodosum, diabetes, and hyperprolactinemia, would be discussed. Methods: From 2015 to 2021, a total of 246 consecutive LGM patients referred to the internal medicine clinic of Ghaem teaching hospital, Mashhad, Iran, were enrolled. Regular assessments were conducted every 3 months until complete symptom resolution. Treatment responses were categorized into five groups: complete resolution, incomplete resolution, resolution with subsequent relapse, no significant improvement, and treatment cessation, with all data meticulously recorded. Telephone follow‐ups were conducted with all patients at the end of the study in December 2022. Results: A total of 156 episodes were analyzed. Prednisone was administered to 136 patients, while oral methotrexate (MTX) was prescribed to 48 cases. The median age of the cohort was 33 years (interquartile range [IQR], 29–38). Of those on prednisone, 57 (41.9%) achieved complete resolution, with 15 (11%) experiencing subsequent relapse, 33 (24.3%) showing no significant improvement, and 31 (19.9%) discontinuing treatment. Among the MTX recipients, 23 (47.9%) achieved complete resolution, while one showed incomplete resolution. Over the median follow‐up of five years (IQR, 4–6), 139 (89.1%) reported complete resolution, nine (5.8%) showed incomplete resolution, and 8 (5.1%) remained symptomatic. The median disease duration was 18 months (IQR, 7–36). Abscess formation during treatment correlated with prolonged disease duration ( p < 0.04), and higher plasma prolactin levels were associated with extended disease duration ( p = 0.001). However, the disease course did not significantly differ in diabetic cases or those with erythema nodosum compared to others. Conclusions: Although more than half of LGM patients experienced no significant improvement, recurrence, or discontinued treatment on prednisone or MTX, however, over a median follow‐up of 5 years, approximately 90% of LGM patients achieved complete resolution within a median course of 18 months. The presence of abscesses during treatment and elevated plasma prolactin levels was linked to longer disease duration.


  • Open Access

    COVID-19 re-infection: a large cross-sectional population-based study in the northeast of Iran

    by Mina AkbariRad, Soheila Ehsani Roodi, Mohammadtaghi Shakeri, Maryam Salari, Amir Mohamad Hashem Asnaashari, Abdollah Firoozi, AmirAli Moodi Ghalibaf

    Today, COVID-19 reinfection has raised further public health concerns than its primary infection; which make major global health concern that going to the possibility of COVID-19 re-infection, and how strong the body’s immunity against this disease in individuals with the previous infection. The present study aimed to investigate the probability of COVID-19 re-infection leading to hospitalization in the population referred to hospitals affiliated with Mashhad University of Medical Sciences, Mashhad, Iran. The present cross-sectional epidemiological study was conducted on patients referred to hospitals affiliated to the Mashhad University of Medical Sciences, Mashhad, Iran supervision with re-infection of COVID-19 from January 21, 2020, to August 23, 2022. The patients had a definite diagnosis through RT-PCR testing in their first and re-infections, with a time interval of at least one month between the two episodes of infection. Out of 125,857 patients evaluated, 9,710 (7.7%) were readmitted with COVID-19 infection more than once, with a time interval of more than one month from their previous hospitalization. The average age of hospitalized patients was 54.8 ± 22.97 years, and more than half were men (51.4%). The most common underlying diseases were hypertension (19.4%) and diabetes (14.8%). cardiovascular diseases, asthma, and cancer were the strongest independent risk factors of COVID-19 re-infection (OR = 2.53, 2.47, and 2.36, respectively, p < 0.001 for all cases). In conclusion, our study demonstrates the importance of understanding the risk factors associated with COVID-19 re-infection and re-hospitalization, particularly in vulnerable populations with comorbidities and substance use disorders.

  • Open Access

    Effects of Probiotics on Thyroid Function and Fatigue in Hypothyroid Patients: A Randomized Placebo Controlled Trial

    by Mina AkbariRad, Zahra Mazloum Khorasani, Anahid Hemmatpur, Abdollah Firoozi, Aida Bakhshi, Sahar Ravanshad, Ali Mofatteh, Hassan Mehrad-Majd

    Objective: Several studies have reported a correlation between gut dysbiosis and primary hypothy roidism. Additionally, probiotics supplementation has been found to alleviate symptoms of hypo thyroidism and its associated side effects. This study aimed to investigate the effect of probiotics supplementation on thyroid function and fatigue severity score (FSS) in hypothyroid patients. Methods: This trial enrolled 80 patients with hypothyroidism. Participants were randomly allocated into intervention and control groups receiving 500 mg/day probiotic (n = 40) or placebo capsules (n = 40) for 12 weeks. Besides FSS and thyroid function factors as primary outcomes, anthropometricindices, levels of c-reactive protein (CRP), liver function markers, and lipid profile were also assessed during follow-up. Results: At baseline, the 2 groups were homogeneous regarding demographic, anthropometric, and clinical parameters except for age, which differed significantly (P = .026). After a 12-week intervention, both groups showed a significant decrease in FSS (P < .001), but the reduction was more effective in the intervention group (P = .002). A significant between-group difference was observed for Body Mass Index (BMI) (P = .007) and Free-T3 (P = .014), with the intervention group showing greater reduction in BMI and more Free-T3 changes at the end of the intervention compared to the controls. A significant decrease in CRP levels occurred only in the intervention group (P = .005). Furthermore, significant improvements occurred in waist circumference (P = .015), free-T4 (P = .012), triglyceride (P = .004), and low-density lipoprotein (P = .001) in the intervention group from pre- to post-treatment. Conclusion: Probiotic supplementation had beneficial effects on fatigue and thyroid function in hypothyroid patients. Further trials with larger sample sizes and prolonged durations are needed for validation. Cite this article as: AkbariRad M, Mazloum Khorasani Z, Hemmatpur A, et al. Effects of probiotics on thyroid function and fatigue in hypothyroid patients: A randomized placebo controlled trial. Endocrinol Res Pract. 2025;29(3):203-210.


  • Open Access

    Impact of Probiotics Administration on the VEGF, Adiponectin, and Glycolipid Metabolism, in Prediabetic Patients: A Randomized, Double‐Blinded, Placebo‐Controlled Clinical Trial

    by Mehrdad Sarabi, Ashkan Torshizian, Zahra Mazloum Khorasani, Abdollah Firoozi, Hassan Mehrad Majd, Nastaran Khoshhal, Nikoo Saeidi, Mina AkbariRad

    It is debated that probiotics can improve glycolipid metabolism and slow the progression of prediabetes to diabetes mellitus. This study aimed to evaluate the effect of probiotics on lipid profile, glucose homeostasis, serum level of resistin, adiponectin, and vascular endothelial growth factor (VEGF) in prediabetic patients. This double‐blind, randomized, placebo‐controlled clinical trial was conducted on prediabetic patients in the Endocrinology clinic of Ghaem Hospital. Patients were randomly divided into two groups: the probiotics group was prescribed a daily 500‐mg capsule of probiotics (109 colony‐forming units), while the other received a placebo capsule with the same appearance. After 3 months, the effect of probiotic administration on laboratory parameters indicative of glycolipid metabolism, resistin, adiponectin, VEGF, body mass index (BMI), and blood pressure was compared between groups. This study was registered in the Iranian Registry of Clinical Trials (IRCT 20190801044405 N2). Fifty‐two patients were included in the final analysis, with 26 patients in each group. The mean age of patients was 43.75 ± 8.45. At the beginning, both groups were similar in all demographic characteristics and measured serum levels of investigated biomarkers (p > 0.05 for all parameters). Both groups exhibited significant changes in BMI and fasting blood sugar (FBS). However, regarding FBS, the magnitude of change was significantly greater in patients treated with probiotics (p = 0.022). Our findings also revealed a significant increase in HDL (p = 0.001), adiponectin (p < 0.001), and VEGF (p = 0.024) serum levels and a significant decrease in HbA1c (p = 0.034), LDL (p = 0.002), TG (p < 0.001), and total cholesterol (p = 0.001) exclusively in the probiotics group. Probiotic supplementation efficiently improved glycolipid metabolism, adiponectin, and VEGF serum levels.


  • Open Access

    The relationship between dose of methotrexate and incidence of liver fibrosis in patients with rheumatoid arthritis

    by Mina AkbariRad, Zahra Rezaieyazdi, Ali Tajik, Banafshe Ataei, Mehrdad Sarabi, Hasan MehradMajd, Hasan Vossoughinia, Abdollah Firoozi

    Introduction: Methotrexate (MTX) is a chemotherapy agent and immune system suppressant that can cause liver fibrosis in long-term usage. This study aimed to investigate the relationship between the dose of MTX and the incidence of liver fibrosis in patients with rheumatoid arthritis (RA).Material and methods: This cohort study was conducted on RA patients with normal liver function who took MTX. Liver FibroScan and laboratory tests, including 2-macroglobulin, total bilirubin, g-glutamyltransferase, apolipoprotein A1, haptoglobin, and alanine transaminase was performed. The patients were divided into 2 groups regarding their cumulative dose of MTX and the rate of liver fibrosis incidence was compared between the 2 groups.Results: In total, 60 RA patients with the mean age of 55.2 ±11.8 years were enrolled. The mean duration of MTX use in patients was 6.9 ±3.8 years, and it was higher in the higher cumulative dose MTX group (> 2 g) than in the lower cumulative dose group (< 2 g; p < 0.0001). The overall prevalence of grade 3 fibrosis was 3.33%. The prevalence of second- and third-degree liver fibrosis in patients receiving a lower cumulative dose was respectively 9 (28.1%) and 1 (3.1%), and in patients receiving a higher cumulative dose it was 7 (25%) and 1 (3.6%), respectively. There was no statistically significant difference between the 2 groups regarding the prevalence of liver fibrosis (p = 0.88). Both aspartate aminotransferase to platelet ratio index and Fibrosis Index Based on 4 Factors indices showed no significant difference between the 2 groups (p = 0.594, p = 0.232).Conclusions: These results suggest that long-term treatment with a higher cumulative dose of MTX is not associated with a higher incidence of liver fibrosis in RA patients.


  • Open Access

    Prevalence, characteristics, and risk factors of non-alcoholic fatty liver disease in North East of Iran: a population-based study

    by Mina AkbariRad, Masoud Pezeshki Rad, Hadi Nobakht, AmirAli Moodi Ghalibaf, Abdollah Firoozi, Ashkan Torshizian, Amir Reza Bina, Ali Beheshti Namdar, Masoumeh Sadeghi

    Background: Nonalcoholic fatty liver disease (NAFLD) is a common dietary disorder caused by fatty changes in the liver parenchyma and hepatocytes without alcohol consumption. The present study aimed to investigate the prevalence, characteristics, and risk factors of NAFLD in the Mashhad Persian Cohort Study population. Method: The present population-based cross-sectional study included all PERSIAN Organizational Cohort study in Mashhad University of Medical Sciences (POCM), Mashhad, Iran by census sampling method. Eligible participants were divided into two groups due to their NAFLD condition (NAFLD positive or NAFLD negative). All enrolled participants were evaluated based on their clinical aspects, anthropometric measures, laboratory tests, and ultrasound features. Statistical analysis was conducted using SPSS software version 16 (SPSS Inc., Chicago, USA –version 16). A P-value less than 0.05 was considered as the significance level. Results: A total of 1198 individuals were included in the study, of which 638 (53.3%) were male and the rest were female. The mean age of the participants was 46.89 ± 8.98 years. A total of 246 patients (20.53%) were NAFLD positive, of which 122 (49.59%) were in grade 1, 112 (45.52%) were in grade 2, and 12 (4.87%) were in grade 3. The prevalence of fatty liver was significantly higher in males than in females (p < 0.001). There were significant differences between NAFLD positive and NAFLD negative participants in terms of having a history of hypertension (P = 0.044), body mass index (P < 0.001), body fat percentage (P = 0.001), waist circumference (P < 0.001), liver craniocaudal length (P = 0.012), fasting blood sugar (FBS) (P = 0.047), aspartate aminotransferase (AST) (P = 0.007), and alanine aminotransferase (ALT) (P = 0.001). Further analysis revealed a strong significant association between BMI, previous history of hypertension, higher levels of serum ALT, and NAFLD (P < 0.05). Conclusion: It can be concluded that ultrasound findings accompanied by laboratory AST and ALT level enzymes could be a cost-benefit approach for NAFLD early diagnosis. The craniocaudal size of the liver could be a beneficent marker for estimating the severity of the disease; however, more studies are recommended to evaluate this variable for future practice against the issue.


  • Open Access

    The Role of Dietary Habits in the Pathogenesis and Development of Inflammatory Bowel Disease: A Narrative Review

    by Mitra Ahadi, Mohammad Reza Rouhbakhsh Zahmatkesh, Parisa Ebrahimi, Mina AkbariRad

    Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic immune-mediated disease. The incidence of IBD is influenced by various genetic and environmental factors, with dietary habits gaining significant scientific interest. While the role of diet in the pathogenesis and development of IBD is still debated, recent studies have demonstrated its potential impact. However, conflicting findings exist regarding the efficacy of dietary interventions in the treatment and control of IBD. This review aimed to summarize the current understanding of the relationship between diet and IBD, highlighting the different perspectives and reasonings observed in recent studies. Overall, it has been shown that dietary habits play a role in the incidence of IBD, and adopting a controlled dietary approach may help manage the disease. Consequently, diet can be considered a predictive and prognostic factor in IBD.


  • Open Access

    The Effect of Telenursing on Disease Outcomes in People with Type 2 Diabetes Mellitus: A Narrative Review

    by Mina AkbariRad, Mohsen Dehghani, Masoumeh Sadeghi, Ashkan Torshizian, Nikoo Saeedi, Mehrdad Sarabi, Mahdieh Sahebi, Mohammad Taghi Shakeri

    Background and Aim. Diabetes is the most common chronic metabolic disease worldwide, requiring life-term follow-up. Telenursing is a suitable method to provide care to people with type 2 diabetes mellitus (T2DM). The present review assessed the effect of telenursing compared to routine care on the outcomes of people with T2DM. Method. A comprehensive search of online databases, including PubMed, Scopus, Cochrane Library, and Google Scholar, was performed using the following MeSH keywords: telenursing, telephone follow-up, diabetes mellitus, disease management, glycemic, self-care, treatment adherence, and quality of life, up to September 2023. Two reviewers independently screened pertinent studies based on the prespecified outcomes (treatment adherence, self-care, glycemic control, and quality of life) and extracted data from all eligible studies. Results. Of all retrieved records, 23 studies including 5 quasiexperimental (21) and 18 randomized controlled trials (RCTs) (79) from five continents met the inclusion criteria. Both male and female patients were considered in the included studies, with mean age of 56.2 years old and a follow-up range of 12 weeks to 18 months. Findings showed that telenursing or nurse telephone follow-up significantly increased mean self-care efficacy score, improved adherence to the treatment regimen, decreased glycosylated hemoglobin and plasma glucose levels (but not lipid profile and body mass index), and improved quality of life compared to the routine care in people with T2DM. Conclusion. Telenursing can effectively supplement healthcare professionals to manage PWT2D. Increasing patients knowledge about their drugs, insulin administration, and diabetes complications improves self-care behaviors and medical adherence. Consistently, improved self-care and regular use of treatment result in improved metabolic indicators and decreased rate of complications, which is associated with a better quality of life.